Natural killer cell activation in mice and men: different triggers for similar weapons? - PubMed (original) (raw)

Review

Natural killer cell activation in mice and men: different triggers for similar weapons?

Francesco Colucci et al. Nat Immunol. 2002 Sep.

Abstract

The signaling pathways that regulate B and T lymphocytes are remarkably conserved between humans and mice. However, recent evidence suggests that the pathways regulating natural killer (NK) cell activation may actually differ between these two species. We discuss the controversies in the field and propose that this divergence could be deceptive: despite some clear differences between human and mouse NK cell receptors, the many ways of activating NK cells and their functions may well be conserved.

PubMed Disclaimer

Similar articles

• Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
  Tassi I, Klesney-Tait J, Colonna M. Tassi I, et al. Immunol Rev. 2006 Dec;214:92-105. doi: 10.1111/j.1600-065X.2006.00463.x. Immunol Rev. 2006. PMID: 17100878 Review.
• Natural killer cell signaling pathways.
  Vivier E, Nunès JA, Vély F. Vivier E, et al. Science. 2004 Nov 26;306(5701):1517-9. doi: 10.1126/science.1103478. Science. 2004. PMID: 15567854
• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
  Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L. Ghiringhelli F, et al. J Exp Med. 2005 Oct 17;202(8):1075-85. doi: 10.1084/jem.20051511. J Exp Med. 2005. PMID: 16230475 Free PMC article.
• Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
  André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P. André P, et al. Eur J Immunol. 2004 Apr;34(4):961-71. doi: 10.1002/eji.200324705. Eur J Immunol. 2004. PMID: 15048706
• Developmental pathways that generate natural-killer-cell diversity in mice and humans.
  Huntington ND, Vosshenrich CA, Di Santo JP. Huntington ND, et al. Nat Rev Immunol. 2007 Sep;7(9):703-14. doi: 10.1038/nri2154. Nat Rev Immunol. 2007. PMID: 17717540 Review.

Cited by

• Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme.
  Cooksey LC, Friesen DC, Mangan ED, Mathew PA. Cooksey LC, et al. Cells. 2024 Sep 17;13(18):1567. doi: 10.3390/cells13181567. Cells. 2024. PMID: 39329751 Free PMC article. Review.
• Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction.
  Chen K, Li Y, Wang B, Yan X, Tao Y, Song W, Xi Z, He K, Xia Q. Chen K, et al. Front Immunol. 2023 May 4;14:1101324. doi: 10.3389/fimmu.2023.1101324. eCollection 2023. Front Immunol. 2023. PMID: 37215109 Free PMC article. Review.
• Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer.
  Felices M, Wesley E, Bendzick LE, Kodal B, Hopps R, Grzywacz B, Hinderlie P, Miller JS, Geller MA. Felices M, et al. Cancer Immunol Res. 2023 May 3;11(5):674-686. doi: 10.1158/2326-6066.CIR-22-0600. Cancer Immunol Res. 2023. PMID: 36807510 Free PMC article.
• Metabolic regulation of NK cell function: implications for immunotherapy.
  Sohn H, Cooper MA. Sohn H, et al. Immunometabolism (Cobham). 2023 Jan 23;5(1):e00020. doi: 10.1097/IN9.0000000000000020. eCollection 2023 Jan. Immunometabolism (Cobham). 2023. PMID: 36710923 Free PMC article. Review.
• Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
  Fernandes de Oliveira Costa A, Olops Marani L, Mantello Bianco T, Queiroz Arantes A, Aparecida Lopes I, Antonio Pereira-Martins D, Carvalho Palma L, Santos Scheucher P, Lilian Dos Santos Schiavinato J, Sarri Binelli L, Araújo Silva C, Kobayashi SS, Agostinho Machado-Neto J, Magalhães Rego E, Samuel Welner R, Lobo de Figueiredo-Pontes L. Fernandes de Oliveira Costa A, et al. Front Immunol. 2022 Sep 23;13:768592. doi: 10.3389/fimmu.2022.768592. eCollection 2022. Front Immunol. 2022. PMID: 36211444 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group